Daily Clout 4/20/22 Report: Pfizer mRNA Construct Researcher/Author: Daniel B. Demers, PhD Reviewed by: Team 5 Team 5 Leader: Linnea Wahl Introduction In the first paragraph of Pfizer document 2.4 NONCLINICAL OVERVIEW, Pfizer states that “BNT162b2 is a nucleoside modified mRNA (modRNA) expressing full-length S [spike] with two proline mutations (P2) to lock the transmembrane […]